Biểu đồ giá cổ phiếu STIM
STIM Dự đoán giá cổ phiếu
Neuronetics Inc
$2.27
-3.4%
$-0.08
Tính đến ngày hôm nay:Aug 06, 13:01:31 GMT-4
Quay lại
Neuronetics Inc (STIM) Dự đoán giá cổ phiếu
Thống kê chính
Giá đóng cửa trước
$2.35
Giá mở cửa
$2.34
Phạm vi ngày
$2.21 - $2.34
Phạm vi 52 tuần
$0.8 - $4.85
Khối lượng
526.8K
Khối lượng trung bình
2.3M
Tỷ suất cổ tức
--
EPS (TTM)
-0.55
Vốn hóa thị trường
$157.9M
STIM là gì?
Neuronetics, Inc. is a commercial stage medical technology company, which focuses on designing, developing and marketing products that improve the quality of life for patients who suffer from neurohealth disorders. The company is headquartered in Malvern, Pennsylvania and currently employs 658 full-time employees. The company went IPO on 2018-06-28. The Company’s NeuroStar Advanced Therapy (NeuroStar Therapy) is a non-drug, noninvasive treatment that can improve the quality of life for people suffering from neurohealth conditions. In addition to selling the NeuroStar Advanced Therapy System (NeuroStar System) and associated treatment sessions to customers, it operates Greenbrook treatment centers across the United States, offering NeuroStar Therapy for the treatment of major depressive disorder (MDD) and other mental health disorders. Spravato is offered to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. MDD is a recurrent disease and follows a fluctuating course over an individual’s lifetime. The firm provides more than 7.1 million treatments to over 1,95,000 patients.
